documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

16 rows where docket_id = "FDA-2020-N-1307" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-1307-0024 FDA None FDA-2020-N-1307 Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals Notice Notice of Approval 2021-12-30T05:00:00Z 2021 12 2021-12-30T05:00:00Z   2021-12-30T14:32:10Z 2021-28362 0 0 0900006484f005cf
FDA-2020-N-1307-0021 FDA None FDA-2020-N-1307 Reference 12 Fisher re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:28:46Z   0 0 0900006484d80e98
FDA-2020-N-1307-0017 FDA None FDA-2020-N-1307 Reference 8 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:22:03Z   0 0 0900006484d80e94
FDA-2020-N-1307-0019 FDA None FDA-2020-N-1307 Reference 10 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:26:01Z   0 0 0900006484d80e96
FDA-2020-N-1307-0023 FDA None FDA-2020-N-1307 Reference 14 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:31:43Z   0 0 0900006484d81167
FDA-2020-N-1307-0018 FDA None FDA-2020-N-1307 Reference 9 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:24:03Z   0 0 0900006484d80e95
FDA-2020-N-1307-0020 FDA None FDA-2020-N-1307 Reference 11 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:27:38Z   0 0 0900006484d80e97
FDA-2020-N-1307-0022 FDA None FDA-2020-N-1307 Reference 13 re: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2021-09-15T04:00:00Z 2021 9     2021-09-15T13:30:08Z   0 0 0900006484d81166
FDA-2020-N-1307-0016 FDA None FDA-2020-N-1307 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Notice 30 Day Proposed Information Collection 2021-09-13T04:00:00Z 2021 9 2021-09-13T04:00:00Z 2021-10-14T03:59:59Z 2021-09-13T13:42:26Z 2021-19690 0 0 0900006484d75b41
FDA-2020-N-1307-0006 FDA None FDA-2020-N-1307 Reference 5 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:34:48Z   0 0 0900006484756910
FDA-2020-N-1307-0007 FDA None FDA-2020-N-1307 Reference 6 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:35:58Z   0 0 0900006484756911
FDA-2020-N-1307-0003 FDA None FDA-2020-N-1307 Reference 1 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:24:56Z   0 0 09000064847560aa
FDA-2020-N-1307-0004 FDA None FDA-2020-N-1307 Reference 2 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:30:10Z   0 0 09000064847560ab
FDA-2020-N-1307-0008 FDA None FDA-2020-N-1307 Reference 4 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:43:31Z   0 0 090000648475690f
FDA-2020-N-1307-0005 FDA None FDA-2020-N-1307 Reference 3 re: Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Supporting & Related Material Background Material 2020-07-14T04:00:00Z 2020 7     2020-07-14T16:29:47Z   0 0 09000064847560ac
FDA-2020-N-1307-0001 FDA None FDA-2020-N-1307 Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials Notice 60 Day Proposed Information Collection 2020-07-07T04:00:00Z 2020 7 2020-07-07T04:00:00Z 2020-09-09T03:59:59Z 2020-09-09T01:02:15Z 2020-14514 0 0 090000648472b55c

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;